Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...

A new chapter in senior living began today as Lily Brook, an independent senior living center, celebrated its official ribbon ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new small ...

We came across a bullish thesis on Eli Lilly and Company on Stock Analysis Compilation’s Substack. In this article, we will ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...

The Cambria County homicide case allegedly involving a Lilly woman was continued Tuesday to the next term of court at the request of the defense. Jennifer L. Bowser will appear before Cambria County ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

It’s understandable. When the path ahead is unclear, the instinct is to pause. To wait.

Eli Lilly is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit ...

However, Lilly is also now an author, having written her first book, “Grass Roots in God’s Truth: Bible Basics.” It’s about a ...